Your browser is no longer supported. Please, upgrade your browser.
Settings
GERN Geron Corporation daily Stock Chart
GERN [NASD]
Geron Corporation
Index- P/E- EPS (ttm)-0.16 Insider Own0.48% Shs Outstand180.00M Perf Week13.08%
Market Cap264.60M Forward P/E- EPS next Y-0.30 Insider Trans-64.16% Shs Float180.00M Perf Month34.86%
Income-27.10M PEG- EPS next Q-0.04 Inst Own35.50% Short Float19.57% Perf Quarter-5.77%
Sales0.90M P/S294.00 EPS this Y5.60% Inst Trans14.69% Short Ratio10.57 Perf Half Y-61.92%
Book/sh1.00 P/B1.47 EPS next Y-87.50% ROA-18.50% Target Price3.63 Perf Year-35.81%
Cash/sh0.92 P/C1.59 EPS next 5Y5.00% ROE-19.20% 52W Range0.95 - 6.99 Perf YTD47.00%
Dividend- P/FCF- EPS past 5Y20.20% ROI-28.20% 52W High-78.97% Beta2.87
Dividend %- Quick Ratio37.80 Sales past 5Y-17.00% Gross Margin- 52W Low53.98% ATR0.10
Employees15 Current Ratio37.80 Sales Q/Q0.00% Oper. Margin- RSI (14)69.10 Volatility7.09% 8.09%
OptionableYes Debt/Eq0.00 EPS Q/Q29.90% Profit Margin- Rel Volume1.04 Prev Close1.42
ShortableYes LT Debt/Eq0.00 EarningsMar 15 AMC Payout- Avg Volume3.33M Price1.47
Recom2.00 SMA2023.43% SMA5023.00% SMA200-48.51% Volume3,461,142 Change3.52%
Jan-31-19Upgrade B. Riley FBR Neutral → Buy $1.50 → $3.25
Oct-02-18Downgrade B. Riley FBR Buy → Neutral $5.75 → $1.50
Jul-05-18Initiated B. Riley FBR, Inc. Buy $5.75
Sep-13-16Reiterated FBR Capital Outperform $6 → $5
Sep-13-16Reiterated FBR & Co. Outperform $6 → $5
Dec-07-15Reiterated Piper Jaffray Overweight $5 → $10
Apr-21-15Initiated Oppenheimer Outperform $5.50
Jun-12-14Upgrade MLV & Co Hold → Buy $2 → $4.25
Mar-12-14Downgrade MLV & Co Buy → Hold $9 → $2
Dec-10-13Upgrade Needham Hold → Buy $10
Dec-10-13Reiterated MLV & Co Buy $8 → $9
Nov-08-13Reiterated MLV & Co Buy $6.50 → $8
Oct-16-13Initiated MLV & Co Buy $6.50
Aug-30-12Initiated Stifel Nicolaus Buy $4
Jun-28-12Initiated Needham Hold
Nov-16-11Downgrade WBB Securities Strong Buy → Speculative Buy $19 → $6
Nov-02-09Downgrade Needham Buy → Hold
Oct-19-09Upgrade Merriman Neutral → Buy
Jul-23-09Downgrade Merriman Buy → Neutral
Jan-26-09Reiterated UBS Neutral $4.50 → $7.25
Feb-13-19 12:50PM  Why Geron Stock Briefly Spiked Today Motley Fool +9.92%
Feb-08-19 07:25AM  Analysis: Positioning to Benefit within National Oilwell Varco, Centene, Paylocity Holding, NorthStar Realty Europe, Geron, and NACCO Industries Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Feb-06-19 08:37AM  Are Options Traders Betting on a Big Move in Geron (GERN) Stock? Zacks
Feb-05-19 08:30AM  Biotech Stocks to Watch ACCESSWIRE -5.07%
Feb-04-19 06:21AM  How Much is Geron Corporations (NASDAQ:GERN) CEO Getting Paid? Simply Wall St. +15.00%
Jan-31-19 04:20PM  Geron Announces Expansion of Leadership Team with Appointment of Chief Medical Officer GlobeNewswire +11.65%
09:20AM  4 Biotech Stocks Making Moves On Thursday (1/31/19) ACCESSWIRE
08:00AM  Biotech Stocks on the Rise ACCESSWIRE
Jan-23-19 08:30AM  Best Ways to Play Biotech Rally ACCESSWIRE
Jan-17-19 08:00AM  Geron Appoints Vice President, Pharmacovigilance and Drug Safety GlobeNewswire
Jan-15-19 09:00AM  Why Geron Stock Dropped 44% in 2018 Motley Fool
Dec-31-18 07:30AM  Geron Announces New Board Leadership Structure GlobeNewswire
Dec-24-18 07:30AM  Biotech Breakout Candidates ACCESSWIRE
Dec-18-18 09:37AM  Here Are Biotechs Big Pipeline Disappointments in 2018 Motley Fool
Dec-13-18 10:13AM  Top 10 Healthcare Stories of 2018 Motley Fool
Dec-05-18 10:35AM  Is Geron Corporation (NASDAQ:GERN) A Financially Sound Company? Simply Wall St.
Dec-03-18 04:22PM  Geron Announces New Overall Survival Data from IMbark in Imetelstat-Treated Patients with Intermediate-2 or High-Risk Myelofibrosis and Relapsed/Refractory to Janus Kinase Inhibitor Therapy GlobeNewswire
06:00AM  Geron Reports Updated Results from Phase 2 Portion of IMerge at the 60th American Society of Hematology Annual Meeting GlobeNewswire
Dec-02-18 05:51PM  The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs Benzinga
Dec-01-18 09:31AM  Geron (GERN) Down 13% Since Last Earnings Report: Can It Rebound? Zacks
Nov-28-18 05:30PM  Geron to Host Analyst and Investor Event on December 10, 2018 GlobeNewswire
Nov-27-18 07:35AM  Research Report Identifies Cheniere Energy Partners, LP, Arena Pharmaceuticals, Geron, Keysight Technologies, Grupo Aeroportuario del Centro Norte S.A.B. de C.V, and Casella Waste with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Nov-14-18 11:35AM  Healthcare Stocks with Turnaround Potential ACCESSWIRE
Nov-12-18 11:30PM  Edited Transcript of GERN earnings conference call or presentation 1-Nov-18 8:30pm GMT Thomson Reuters StreetEvents
Nov-07-18 04:30PM  Geron to Present at Upcoming Investor Conferences in November GlobeNewswire
Nov-06-18 06:55AM  Today's Research Reports on Trending Tickers: bluebird bio and Geron ACCESSWIRE -6.78%
Nov-02-18 10:43AM  MARKETS: Today's job numbers might have been too good and could spook stocks Yahoo Finance Video -9.73%
10:42AM  How Geron's Horrible Year Is a Great Reminder to Investors Motley Fool
09:15AM  Geron's (GERN) Q3 Earnings Beat, Revenues Miss, Shares Down Zacks
07:30AM  Geron (GERN) Reports Q3 Loss, Misses Revenue Estimates Zacks
05:07AM  Geron: 3Q Earnings Snapshot Associated Press
Nov-01-18 08:21PM  Scary Markets, Frightening Stocks, and How to Keep From Panicking Motley Fool +20.92%
04:05PM  Geron Corporation Reports Third Quarter 2018 Financial Results and Recent Company Events GlobeNewswire
02:55PM  Why Geron Corporation Stock Is Ripping Higher Today Motley Fool
06:20AM  Geron Announces Two Oral Presentations on Imetelstat at Upcoming American Society of Hematology Annual Meeting GlobeNewswire
Oct-29-18 09:58AM  What's in the Cards for Geron (GERN) This Earnings Season? Zacks
08:00AM  Today's Research Reports on Trending Tickers: Amicus Therapeutics and Geron ACCESSWIRE
Oct-25-18 06:00AM  Geron to Announce Third Quarter 2018 Financial Results on November 1, 2018 GlobeNewswire
Oct-15-18 08:20AM  Report: Developing Opportunities within CorEnergy Infrastructure Trust, Calumet Specialty Products Partners, Iron Mountain, Geron, Bruker, and Loews Future Expectations, Projections Moving into 2018 GlobeNewswire
Oct-10-18 05:45PM  Geron (GERN) Stock Moves -0.58%: What You Should Know Zacks
Oct-09-18 10:05AM  Here's Why Geron Plummeted 69% in September Motley Fool -5.98%
08:49AM  Do Options Traders Know Something About Geron (GERN) Stock We Don't? Zacks
Oct-08-18 11:15AM  Are These Beaten-Down Clinical-Stage Biotech Stocks Buys? Motley Fool
09:25AM  Geron Stock: Buy, Sell, or Hold? Motley Fool
Oct-03-18 10:54AM  Biotech Stock Roundup: ALXN on Acquisition Spree, FDA Nod for REGN, AMGN Drugs Zacks +6.43%
Sep-30-18 09:47AM  Benzinga's Bulls & Bears Of The Week: Apple, GE, IBM, Nike, Tesla And More Benzinga
Sep-29-18 07:15AM  2 Stocks That Could Benefit Big From Geron's Stumble Motley Fool
Sep-28-18 09:15PM  INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Geron Corp. Business Wire -23.81%
11:30AM  Why Geron Corporation's Stock Is Sinking, Again Motley Fool
10:30AM  Stem Cell Companies Moving The Markets ACCESSWIRE
09:42AM  Geron's Stock Plunges as J&J Ends Imetelstat Collaboration Zacks
09:20AM  Can Geron Corporation Recover From Its Breakup With Johnson & Johnson? Motley Fool
09:16AM  After Its Disastrous Day, What's Next for Geron Corp.? Motley Fool
08:26AM  Today's Research Reports on Stocks to Watch: RXi Pharmaceuticals and Geron ACCESSWIRE
06:16AM  Better Buy: Geron Corporation vs. Incyte Corporation Motley Fool
Sep-27-18 05:41PM  INVESTOR ALERT: Kaskela Law LLC Announces Investigation of Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire -62.92%
04:41PM  Apple, Amazon and WellCare rise while Carnival skids Associated Press
04:37PM  Why Bed Bath & Beyond, Geron, and Canopy Growth Slumped Today Motley Fool
03:59PM  5 Top Stock Trades for Friday BBBY, RAD and NFLX InvestorPlace
02:48PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Geron Corporation (GERN) PR Newswire
10:00AM  Investor Alert: Kaplan Fox Investigates Geron Corporation PR Newswire
09:39AM  Higher open puts stock market on track to halt multisession skid as traders absorb data, Fed hike MarketWatch
08:33AM  Geron Plunges 68% After J&J Ends Partnership That Had Ignited Stock Bloomberg
08:20AM  The Daily Biotech Pulse: Hologic Goes Shopping, Johnson & Johnson Snaps Ties With Geron Benzinga
08:20AM  Shares of biotech firm Geron fall 70% after Johnson & Johnson ends collaboration CNBC
08:04AM  Geron's stock plunges to pace all premarket losers after Janssen terminates CLA MarketWatch
07:34AM  Why Geron Corporation's Stock Is Getting Hammered Today Motley Fool
06:00AM  Geron Announces Discontinuation of Imetelstat Collaboration by Janssen GlobeNewswire
Sep-26-18 08:30PM  Geron to Provide an Update on the Imetelstat Collaboration with Janssen on September 27, 2018 GlobeNewswire
Sep-25-18 02:02PM  Who Are Geron Corporations (NASDAQ:GERN) Major Shareholders? Simply Wall St.
10:30AM  This Stock Soared 1487% in the Last Month ACCESSWIRE
Sep-24-18 11:23AM  Why Geron Corporation Stock Is Bolting Higher Today Motley Fool +13.55%
08:00AM  Today's Research Reports on Trending Tickers: Geron and ACADIA Pharmaceuticals ACCESSWIRE
Sep-19-18 02:38PM  7 Biotech Stocks to Buy Now InvestorPlace
10:30AM  Stem Cell Deals Moving the Markets ACCESSWIRE
Sep-17-18 08:00AM  Today's Research Reports on Trending Tickers: Geron and Arrowhead Pharmaceuticals ACCESSWIRE
Sep-16-18 02:22PM  The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs Benzinga
Sep-14-18 01:05PM  Major Stem Cell Breakthroughs Giving Investors Big Opportunity ACCESSWIRE
Sep-13-18 08:54AM  Options Traders Expect Huge Moves in Geron (GERN) Stock Zacks -5.19%
Sep-12-18 10:27AM  Geron Corp: Lost in Translation? Motley Fool
Sep-11-18 10:00AM  Geron Corporation: A Sober Assessment Motley Fool -8.41%
Sep-07-18 11:00AM  3 Stocks to Watch as Immunotherapy Pushes Biotech Growth ACCESSWIRE
Sep-06-18 11:10AM  5 Biotech Stocks to Watch ACCESSWIRE
Sep-05-18 09:23AM  3 Biotech Stocks That Still Have Major Catalysts in September Motley Fool
06:00AM  3 Top Stocks Under $10 Motley Fool
Sep-04-18 10:33AM  Geron Stock Up More Than 200% in 2018 So Far: Here's Why Zacks
Sep-02-18 05:49PM  Why Geron Corp. Soared 59.6% in August Motley Fool
09:41AM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings Benzinga
09:10AM  3 Biotech Stocks That Could Soar Next Week Motley Fool
Aug-30-18 10:39AM  Why Is Geron (GERN) Up 58% Since Last Earnings Report? Zacks
08:00AM  Biotech and Cannabis Stocks Preparing to Breakout ACCESSWIRE
Aug-28-18 04:30PM  Why Yum China Holdings, Brooks Automation, and Geron Jumped Today Motley Fool +14.05%
12:56PM  Why Geron Corporation's Stock Is Charging Higher Today Motley Fool
09:29AM  Johnson & Johnson Is Hiring -- and It's Ginormous News for Geron Motley Fool
Aug-27-18 11:00AM  Has Geron Corporation's Stock Been De-Risked? Motley Fool -6.74%
Aug-24-18 11:17AM  3 Biotech Stocks Hitting New Highs in August 2018 ACCESSWIRE +28.78%
Aug-20-18 08:00AM  Today's Research Reports on Trending Tickers: Ligand Pharmaceuticals and Geron ACCESSWIRE
Aug-16-18 08:44AM  Better Speculative Biotech Stock: Amarin Corporation vs. Geron Corporation Motley Fool
Aug-14-18 08:00AM  Recent Analysis Shows Automatic Data Processing, Denbury Resources, ITT, Cardinal Health, Geron, and The Hackett Group Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Aug-13-18 09:00AM  Implied Volatility Surging for Geron (GERN) Stock Options Zacks
Geron Corporation operates as a biopharmaceutical company. The company supports the clinical stage development of imetelstat, a telomerase inhibitor for the treatment of hematologic myeloid malignancies. It has collaboration and license agreement with Janssen Biotech, Inc. to develop and commercialize imetelstat worldwide for indications in oncology, including hematologic myeloid malignancies and other human therapeutic uses. The company was founded in 1990 and is based in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Spiegel Robert J.DirectorSep 13Option Exercise2.95175,000516,550110,576Sep 13 09:28 PM
Spiegel Robert J.DirectorSep 13Sale6.85175,0001,198,75065,576Sep 13 09:28 PM
ROSENFIELD STEPHENEVP, Genl Counsel & SecretaryAug 24Option Exercise1.891,362,2502,572,745425,000Aug 24 09:32 PM
ROSENFIELD STEPHENEVP, Genl Counsel & SecretaryAug 24Sale4.511,362,2506,143,7480Aug 24 09:32 PM